[ABMD] ABIOMED, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization: 5.06 B

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 112.38 Change: 0.83 (0.74%)
Ext. hours: Change: 0 (0%)

chart ABMD

Refresh chart

Strongest Trends Summary For ABMD

ABMD is in the long-term up 1269% in 10 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart fai

Fundamental Ratios
Shares Outstanding42.99 M EPS1.16 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 38.41% Sales Growth - Q/Q8.95% P/E123.61
P/E To EPS Growth P/S21.98 P/BV17.37 Price/Cash Per Share38.37
Price/Free Cash Flow132.89 ROA33.6% ROE38.99% ROI
Current Ratio5.6 Quick Ratio5.17 Long Term Debt/Equity Debt Ratio0.13
Gross Margin82.66% Operating Margin12.45% Net Profit Margin49.36% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities9.52 M Cash From Investing Activities-49.86 M Cash From Operating Activities43.29 M Gross Profit56.75 M
Net Profit98.87 M Operating Profit12.36 M Total Assets338.37 M Total Current Assets220.14 M
Total Current Liabilities39.32 M Total Debt Total Liabilities46.81 M Total Revenue67.56 M
Technical Data
High 52 week446.21 Low 52 week170.55 Last close260.48 Last change-0.63%
RSI38.18 Average true range12.1 Beta1.14 Volume141.67 K
Simple moving average 20 days-1.81% Simple moving average 50 days-8.37% Simple moving average 200 days-16.62%
Performance Data
Performance Week0.6% Performance Month3.57% Performance Quart-28.06% Performance Half-11.16%
Performance Year48% Performance Year-to-date-35.84% Volatility daily1.9% Volatility weekly4.24%
Volatility monthly8.69% Volatility yearly30.11% Relative Volume291.59% Average Volume739.39 K
New High New Low

News

2020-06-05 09:41:00 | FDA Approves Abiomed’s First-in-Human Trial of Impella ECP, World’s Smallest Heart Pump

2020-06-03 16:30:00 | Abiomed to Hold Fireside Chat at the William Blair 40th Annual Growth Stock Conference

2020-06-03 09:35:01 | ABIOMED's ABMD Impella RP Receives FDA's EUA Clearance

2020-06-01 12:27:00 | Coronavirus update: Global case tally tops 6 million as weekend protests spark concerns they will lead to an increase in infections

2020-06-01 12:06:42 | Abiomed’s Heart Pump Gets FDA Emergency Use Status For Covid-19 Patients

2020-06-01 08:03:42 | FDA approves emergency use of Abiomed heart pump for COVID-19 patients

2020-06-01 07:42:00 | Abiomed gets emergency authorization to use heart pump in COVID-19 patients

2020-06-01 07:00:00 | FDA Issues Emergency Use Authorization for Impella RP as Therapy for COVID-19 Patients with Right Heart Failure

2020-05-30 11:31:03 | Why Is Abiomed ABMD Up 17.1% Since Last Earnings Report?

2020-05-27 16:30:00 | Abiomed to Hold Fireside Chat at Jefferies Virtual Healthcare Conference

2020-05-27 11:40:03 | HOLX vs. ABMD: Which Stock Should Value Investors Buy Now?

2020-05-20 07:00:00 | Abiomed to Host Virtual Clinical Data and Innovation Day

2020-05-19 09:32:00 | PROTECT III Study Shows Placing Impella Prior to High-Risk PCI is Associated with Lower Mortality Compared to Bailout PCI

2020-05-15 10:38:04 | Is There Now An Opportunity In Abiomed ABMD Stock?

2020-05-11 14:39:47 | This is the _kitchen sink quarter_ for every company out there: Expert

2020-05-11 14:32:00 | Why Did Abiomed Go Up 31.8% in April?

2020-05-05 10:09:14 | Why Abiomed's Stock Price Jumped Last Week

2020-05-05 10:09:14 | Why Abiomed's Stock Price Jumped Last Week

2020-05-03 08:06:46 | Abiomed, Inc. NASDAQ:ABMD Analysts Are Cutting Their Estimates: Here's What You Need To Know

2020-05-01 06:25:37 | A Rising Share Price Has Us Looking Closely At Abiomed, Inc.'s NASDAQ:ABMD P/E Ratio

2020-04-30 18:17:01 | Edited Transcript of ABMD earnings conference call or presentation 30-Apr-20 12:00pm GMT

2020-04-30 15:44:00 | Why Abiomed Stock Soared Today

2020-04-30 14:30:37 | Abiomed Inc ABMD Q4 2020 Earnings Call Transcript

2020-04-30 14:06:00 | Abiomed Soars 16% on Acquisition and an Earnings Beat

2020-04-30 10:30:02 | ABIOMED ABMD Q4 Earnings Beat Estimates, Revenues Miss

2020-04-30 08:35:12 | Abiomed ABMD Beats Q4 Earnings Estimates

2020-04-30 07:00:00 | Abiomed Announces Q4 FY 2020 Revenue of $207 Million and 28.1% Operating Margin

2020-04-29 19:29:00 | Abiomed Expands Product Portfolio with Acquisition of Cardiopulmonary Support Technology ECMO to Improve Outcomes for Patients

2020-04-29 11:09:03 | Medical Products Stock Earnings on Apr 30: BAX, IDXX & More

2020-04-24 09:59:01 | ABIOMED ABMD to Report Q4 Earnings: What's in the Cards?

2020-04-23 12:32:04 | Earnings Preview: Abiomed ABMD Q4 Earnings Expected to Decline

2020-04-10 07:00:00 | Abiomed Fourth Quarter Fiscal 2020 Earnings and Conference Call Notification

2020-04-08 06:21:57 | Does Abiomed NASDAQ:ABMD Deserve A Spot On Your Watchlist?

2020-03-26 11:40:03 | IART vs. ABMD: Which Stock Is the Better Value Option?

2020-03-25 07:05:00 | Abiomed’s Response to the COVID-19 Pandemic

2020-03-22 23:05:30 | Hedge Funds Have Never Been This Bullish On ABIOMED, Inc. ABMD

2020-03-19 19:11:34 | Finding Companies That Can Survive Hard Times

2020-03-10 11:40:03 | IART vs. ABMD: Which Stock Should Value Investors Buy Now?

2020-03-09 10:13:02 | Neovasc NVCN Releases Update on Reducer and Tiara Products

2020-03-09 07:23:54 | Is Abiomed, Inc.'s NASDAQ:ABMD ROE Of 23% Impressive?

2020-03-07 11:30:04 | Abiomed ABMD Down 19.9% Since Last Earnings Report: Can It Rebound?

2020-03-04 07:05:00 | Study of 21,848 High-Risk PCI Patients Demonstrates Lower Risk of Death and Complications in Patients who Receive PVADs Impella

2020-02-21 15:07:00 | Wall Street has slashed these S&P 500 companies’ estimates by as much as 70%

2020-02-10 11:47:55 | Wall Street Opens Higher Monday

2020-02-10 05:30:43 | Abiomed, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year

2020-02-07 16:01:47 | US Stock Market Red on Friday

2020-02-06 17:18:48 | Edited Transcript of ABMD earnings conference call or presentation 6-Feb-20 1:00pm GMT

2020-02-06 09:30:02 | ABIOMED ABMD Earnings Beat Estimates in Q3, Revenues Miss

2020-02-06 07:00:00 | Abiomed Announces Q3 FY 2020 Revenue of $222 Million and 31.7% Operating Margin

2020-02-06 06:00:00 | ABIOMED, Inc. to Host Earnings Call